Cannabinoid Science and Medicine

Presented by Jennifer L. Triemstra, MS, PhD 
and Joanne Wagner, PT, PhD

Medical Science Liaisons for Greenwich Biosciences

Thursday, November 8, 2018 - 9:00 am to 11:00 am

       Free: 1.75 CEU's for attending this training 

                                                (IAODAPCA Included)

Who Should Attend: Psychiatrist (MD), Psychiatric Nurse (RN), Psychologist (Ph.D), Social Worker (MSW), Mental Health Counselor, Mental Health Therapist, Psychiatric Nurse Practitioner (ARNP), and other mental health professionals. 

Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. 

The field of cannabinoid science seeks to understand the structure, properties, and pharmacology of specific cannabinoids, and their potential applications for therapeutic purposes.

Summary of training:

This presentation will provide an overview of cannabinoid science and an update on FDA-approved products derived from cannabidiol (CBD)

Key Learning Objectives:

• Describe the history and current regulation of medicinal cannabis in the US
• Introduce cannabinoid science & the therapeutic potential of cannabinoids
• Share web-based resources for cannabinoid science education
• Overview the safety and efficacy of CBD in randomized clinical trials in epilepsy

Presenter: Jennifer L. Marlo-Triemstra, MS, PhD

Jennifer is a Medical Science Liaison for Greenwich Biosciences and helping develop a pharmaceutical-grade, investigational cannabidiol therapy for the treatment of seizures associated with epilepsy.  Jennifer received her Masters of Science from State Cloud State University and her PhD at the University of Minnesota.  Before graduate school, Jennifer spent several years working in academia performing laboratory research focused on neuroendocrinology.  She currently lives in Minneapolis with her spouse, 2 children, and a fish named ‘Pete’.

Presenter: Joanne Wagner, PT, PhD

Joanne (Jo) received her Ph.D. in Movement Science from Washington University in St. Louis (WUSTL) under the mentorship of Catherine Lang PT, PhD and Alexander Dromerick, MD.  Her research focused primarily on elucidating the neuromuscular mechanisms underlying improved motor function following stroke in adults, with an emphasis on acute recovery. 

Upon completion of her Ph.D., Jo continued her training as a post-doctoral fellow in the lab of Carolyn Patten PT, PhD at the Veteran’s Affairs Rehabilitation Research Center of Excellence, Palo Alto Health Care System and Stanford University.  There she aimed to elucidate the role of central vs. peripheral neuromuscular deficits in impaired function in chronic stroke survivors.

In August of 2017, Jo joined Greenwich Biosciences as a medical science liaison.  She resides in St. Louis, Missouri.   Her territory includes Missouri, Kansas (Kansas City), Indiana, Illinois (not Chicago), and Kentucky.